Rünkorg K - Search Results

1

Distinct changes in the behavioural effects of morphine and naloxone in CCK2 receptor-deficient mice.

Rünkorg K, Veraksits A, Kurrikoff K, Luuk H, Raud S, Abramov U, Matsui T, Bourin M, Kõks S, Vasar E. Rünkorg K, et al. Behav Brain Res. 2003 Sep 15;144(1-2):125-35. doi: 10.1016/s0166-4328(03)00070-6. Behav Brain Res. 2003. PMID: 12946603

2

Altered pain sensitivity and morphine-induced anti-nociception in mice lacking CCK2 receptors.

Veraksits A, Rünkorg K, Kurrikoff K, Raud S, Abramov U, Matsui T, Bourin M, Kõks S, Vasar E. Veraksits A, et al. Among authors: runkorg k. Psychopharmacology (Berl). 2003 Mar;166(2):168-75. doi: 10.1007/s00213-002-1333-6. Epub 2003 Jan 24. Psychopharmacology (Berl). 2003. PMID: 12545332

3

Targeted mutation of CCK2 receptor gene modifies the behavioural effects of diazepam in female mice.

Raud S, Rünkorg K, Veraksits A, Reimets A, Nelovkov A, Abramov U, Matsui T, Bourin M, Volke V, Kõks S, Vasar E. Raud S, et al. Among authors: runkorg k. Psychopharmacology (Berl). 2003 Aug;168(4):417-25. doi: 10.1007/s00213-003-1453-7. Epub 2003 Apr 23. Psychopharmacology (Berl). 2003. PMID: 12709779

4

Differences in behavioural effects of amphetamine and dopamine-related gene expression in wild-type and homozygous CCK2 receptor deficient mice.

Rünkorg K, Värv S, Matsui T, Kõks S, Vasar E. Rünkorg K, et al. Neurosci Lett. 2006 Oct 2;406(1-2):17-22. doi: 10.1016/j.neulet.2006.07.016. Epub 2006 Aug 17. Neurosci Lett. 2006. PMID: 16916582

5

Rimonabant attenuates amphetamine sensitisation in a CCK2 receptor-dependent manner.

Rünkorg K, Orav L, Kõks S, Matsui T, Volke V, Vasar E. Rünkorg K, et al. Behav Brain Res. 2012 Jan 1;226(1):335-9. doi: 10.1016/j.bbr.2011.09.005. Epub 2011 Sep 12. Behav Brain Res. 2012. PMID: 21925544

6

Cholecystokinin2 receptor-deficient mice display altered function of brain dopaminergic system.

Kõks S, Volke V, Veraksits A, Rünkorg K, Sillat T, Abramov U, Bourin M, Huotari M, Männistö PT, Matsui T, Vasar E. Kõks S, et al. Among authors: runkorg k. Psychopharmacology (Berl). 2001 Nov;158(2):198-204. doi: 10.1007/s002130100855. Psychopharmacology (Berl). 2001. PMID: 11702094

7

Exenatide Is an Effective Antihyperglycaemic Agent in a Mouse Model of Wolfram Syndrome 1.

Sedman T, Rünkorg K, Krass M, Luuk H, Plaas M, Vasar E, Volke V. Sedman T, et al. Among authors: runkorg k. J Diabetes Res. 2016;2016:9239530. doi: 10.1155/2016/9239530. Epub 2016 Mar 16. J Diabetes Res. 2016. PMID: 27069934 Free PMC article.

8

Tolerance develops toward GLP-1 receptor agonists' glucose-lowering effect in mice.

Sedman T, Krass M, Rünkorg K, Vasar E, Volke V. Sedman T, et al. Among authors: runkorg k. Eur J Pharmacol. 2020 Oct 15;885:173443. doi: 10.1016/j.ejphar.2020.173443. Epub 2020 Aug 1. Eur J Pharmacol. 2020. PMID: 32750365

9

Acute administration of GLP-1 receptor agonists induces hypolocomotion but not anxiety in mice.

Krass M, Rünkorg K, Vasar E, Volke V. Krass M, et al. Among authors: runkorg k. Acta Neuropsychiatr. 2012 Oct;24(5):296-300. doi: 10.1111/j.1601-5215.2012.00648.x. Acta Neuropsychiatr. 2012. PMID: 25286994 No abstract available.

10

GLP-1 receptor agonists have a sustained stimulatory effect on corticosterone release after chronic treatment.

Krass M, Volke A, Rünkorg K, Wegener G, Lund S, Abildgaard A, Vasar E, Volke V. Krass M, et al. Among authors: runkorg k. Acta Neuropsychiatr. 2015 Feb;27(1):25-32. doi: 10.1017/neu.2014.36. Epub 2014 Dec 3. Acta Neuropsychiatr. 2015. PMID: 25469828

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14 results

Search Page

Filters